We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGS
301
DELISTED
PlayAGS
AGS
| $9.31M | 0.08% |
478,619
-365,319
| -43% | -$7.86M |
|
|
FOLD
302
DELISTED
Amicus Therapeutics
FOLD
| $9.26M | 0.08% |
742,236
+573,235
| +339% | +$7.27M |
|
303
Planet Fitness
PLNT
$4.43B
| $9.21M | 0.08% |
+127,110
| New | +$9.58M |
|
|
CARB
304
DELISTED
Carbonite Inc
CARB
| $9.21M | 0.08% |
353,543
-12,496
| -3% | -$305K |
|
305
Freshpet
FRPT
$3.01B
| $9.16M | 0.08% |
201,244
+143,041
| +246% | +$6.48M |
|
306
Ingredion
INGR
$6.48B
| $9.13M | 0.08% |
+110,676
| New | +$9.52M |
|
307
Reinsurance Group of America
RGA
$15.9B
| $9.1M | 0.07% |
58,321
+24,308
| +71% | +$3.64M |
|
308
CVS Health
CVS
$140B
| $9.03M | 0.07% |
+165,693
| New | +$8.92M |
|
309
Factset
FDS
$10.1B
| $9.03M | 0.07% |
31,504
+31,162
| +9,112% | +$8.62M |
|
|
MYOK
310
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $9.03M | 0.07% |
180,060
-275,359
| -60% | -$13.4M |
|
311
Mastercard
MA
$497B
| $9.02M | 0.07% |
34,088
-1,347
| -4% | -$337K |
|
312
America's Car Mart
CRMT
$27.1M
| $8.98M | 0.07% |
104,366
+64,166
| +160% | +$5.9M |
|
313
Labcorp
LH
$25.8B
| $8.96M | 0.07% |
+60,289
| New | +$8.41M |
|
314
Huazhu Hotels Group
HTHT
$13.2B
| $8.91M | 0.07% |
+245,731
| New | +$9.19M |
|
315
SiriusXM
SIRI
$10.7B
| $8.9M | 0.07% |
159,513
-403,836
| -72% | -$23M |
|
316
Elanco Animal Health
ELAN
$12.7B
| $8.9M | 0.07% |
+263,275
| New | +$8.55M |
|
|
NXGN
317
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $8.83M | 0.07% |
443,668
+277,463
| +167% | +$5.18M |
|
318
Halozyme
HALO
$9.9B
| $8.81M | 0.07% |
513,083
+467,136
| +1,017% | +$7.54M |
|
319
Innoviva
INVA
$1.61B
| $8.81M | 0.07% |
605,409
+560,984
| +1,263% | +$7.95M |
|
320
Diodes
DIOD
$3.69B
| $8.81M | 0.07% |
242,237
-11,964
| -5% | -$423K |
|
|
LX
321
LexinFintech Holdings
LX
$239M
| $8.65M | 0.07% |
774,750
+199,135
| +35% | +$2.48M |
|
322
Oxford Industries
OXM
$613M
| $8.62M | 0.07% |
+113,695
| New | +$8.7M |
|
323
DXC Technology
DXC
$1.76B
| $8.61M | 0.07% |
156,080
+149,607
| +2,311% | +$8.66M |
|
324
Advanced Drainage Systems
WMS
$11.1B
| $8.61M | 0.07% |
262,474
-443,444
| -63% | -$12.8M |
|
325
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $8.57M | 0.07% |
98,291
-95,630
| -49% | -$8.26M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.